{
    "medical_history": {
        "chief_complaint": "Acute hepatotoxicity following remdesivir therapy in a COVID-19 patient.",
        "history_of_present_illness": "The patient had a 7-day history of fever, headache, cough, and progressive dyspnea prior to admission. After starting remdesivir on day 16 of hospitalization, acute increases in alanine transaminase (ALT) and aspartate transaminase (AST) were observed five days later, leading to the discontinuation of remdesivir.",
        "past_medical_history": "Hypertension and hypercholesterolemia treated with enalapril, amlodipine, and simvastatin.",
        "family_history": "Not specified.",
        "social_history": "The patient did not smoke or use illicit drugs."
    }
}